248 related articles for article (PubMed ID: 35621685)
21. Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
Donà MG; Rollo F; Pichi B; Moretto S; Covello R; Pellini R; Benevolo M
Oral Oncol; 2022 Aug; 131():105947. PubMed ID: 35667293
[No Abstract] [Full Text] [Related]
22. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
23. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
24. The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer.
Regan SN; Mierzwa ML
Cancer J; 2023 Jul-Aug 01; 29(4):226-229. PubMed ID: 37471613
[TBL] [Abstract][Full Text] [Related]
25. Has the time come for de-escalation in the management of oropharyngeal carcinoma?
Durkova J; Boldis M; Kovacova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):293-301. PubMed ID: 31796941
[TBL] [Abstract][Full Text] [Related]
26. HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?
Bates JE; Steuer CE
Curr Treat Options Oncol; 2022 Mar; 23(3):325-332. PubMed ID: 35244886
[TBL] [Abstract][Full Text] [Related]
27. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
28. Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management.
De Santis S; Spinosi MC; Cambi J; Bengala C; Boccuzzi S
J Stomatol Oral Maxillofac Surg; 2017 Apr; 118(2):103-108. PubMed ID: 28345518
[TBL] [Abstract][Full Text] [Related]
29. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
[TBL] [Abstract][Full Text] [Related]
30. Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mirza FA; Johnson CZ; Byrd JK; Albergotti WG
Head Neck; 2021 Nov; 43(11):3476-3492. PubMed ID: 34499392
[TBL] [Abstract][Full Text] [Related]
31. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
32. Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Zhou S; Chan C; Rulach R; Dyab H; Hendry F; Maxfield C; Dempsey MF; James A; Grose D; Lamb C; Schipani S; Wilson C; Cheng Lau Y; Paterson C
Oral Oncol; 2022 May; 128():105870. PubMed ID: 35447564
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-related oropharyngeal cancer.
Taberna M; Mena M; Pavón MA; Alemany L; Gillison ML; Mesía R
Ann Oncol; 2017 Oct; 28(10):2386-2398. PubMed ID: 28633362
[TBL] [Abstract][Full Text] [Related]
35. Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
Zarrabi KK; Galloway TJ; Flieder DB; Kumar SS; Judd J; Bauman JR
Head Neck; 2022 Aug; 44(8):E25-E30. PubMed ID: 35546490
[TBL] [Abstract][Full Text] [Related]
36. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
37. Should We De-escalate the Treatment for HPV-Positive Tumors?
Dietz A; Wichmann G; Wiegand S
Recent Results Cancer Res; 2017; 206():173-181. PubMed ID: 27699538
[TBL] [Abstract][Full Text] [Related]
38. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
39. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
40. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
